BRIEF published on 05/23/2025 at 07:57, 1 year 5 months ago AB Science renforce sa trésorerie avec une augmentation de capital Euronext Paris Financement Augmentation De Capital Investisseurs AB Science
BRIEF published on 05/23/2025 at 07:57, 1 year 5 months ago AB Science strengthens its cash flow with a capital increase Euronext Paris Investors Funding Capital Increase AB Science
PRESS RELEASE published on 05/23/2025 at 07:52, 1 year 5 months ago AB Science : AB Science a réalisé avec succès une augmentation de capital de 1,8 million d’euros renforçant sa trésorerie et couvrant ses besoins de financement. Découvrez les détails dans ce communiqué de presse Augmentation De Capital Trésorerie AB Science Masitinib AB8939
PRESS RELEASE published on 05/23/2025 at 07:52, 1 year 5 months ago AB Science announces the settlement delivery of its latest capital increase for €1.8 million AB Science settles €1.8 million capital increase to strengthen cash position and cover financing needs; focuses on innovative drug development for various diseases Healthcare Industry Financial News Capital Increase Drug Development AB Science
BRIEF published on 05/20/2025 at 07:54, 1 year 5 months ago AB Science Completes EUR 1.8 Million Private Placement Private Placement Euronext Paris Share Warrants AB Science AB8939 Development
BRIEF published on 05/20/2025 at 07:54, 1 year 5 months ago AB Science finalise un placement privé de 1,8 million d'euros Euronext Paris Placement Privé Bons De Souscription D'actions AB Science Développement AB8939
PRESS RELEASE published on 05/20/2025 at 07:49, 1 year 5 months ago AB Science announces the successful completion of a EUR 1.8 million private placement AB Science successfully completes EUR 1.8 million private placement for clinical development. New shares issued with warrants attached for financing ongoing activities Private Placement Capital Increase Clinical Development Share Issuance AB Science
PRESS RELEASE published on 05/20/2025 at 07:49, 1 year 5 months ago AB Science annonce le succès d'un placement privé de 1,8 millions d'euros AB Science annonce le succès d’un placement privé d’environ 1,8 million d’euros pour financer le développement clinique du programme AB8939 Financement Placement Privé Développement Clinique AB Science AB8939
BRIEF published on 05/19/2025 at 07:56, 1 year 5 months ago AB Science obtient un brevet en Chine pour le masitinib contre la COVID-19 COVID-19 Antiviral AB Science Masitinib Brevet Chinois
BRIEF published on 05/19/2025 at 07:56, 1 year 5 months ago AB Science obtains a patent in China for masitinib against COVID-19 COVID-19 Antiviral AB Science Masitinib Chinese Patent
Published on 10/29/2026 at 13:31, 2 hours 8 minutes ago First Breach Advances Ammunition and Drone Manufacturing Expansion as U.S. Reshoring Accelerates
Published on 10/29/2026 at 13:00, 2 hours 39 minutes ago NuRAN Wireless Secures US$10 Million Non-Dilutive Facility and Confirms No ATM Sales at Current Market Levels
Published on 10/29/2026 at 13:00, 2 hours 39 minutes ago Core Silver Unveils Multiple New Broad Copper-Bearing VMS Intercepts at the Touleary Discovery Zone
Published on 10/29/2026 at 12:35, 3 hours 4 minutes ago ESGold Advances Historic Mine Waste Reclamation With MOU for Up to 300,000 Tonnes of Aggregate Annually
Published on 10/29/2026 at 12:30, 3 hours 9 minutes ago AIML Subsidiary NeuralCloud Signs Agreement with Etisense to Advance Animal-Model ECG Labeling with MaxYield(TM)
Published on 10/29/2026 at 15:17, 22 minutes ago EQS-Adhoc: Basler AG preliminary 9-month result: Again increase of forecast 2026 after continued high incoming orders and strong results
Published on 10/29/2026 at 15:05, 34 minutes ago Rockwell Automation Introduces SecureOT Capabilities to Help OEMs Address Emerging Cybersecurity Regulations
Published on 10/29/2026 at 14:55, 44 minutes ago Ondo Intelligent Portfolios Lineup Expands to Solana
Published on 10/29/2026 at 14:13, 1 hour 26 minutes ago Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
Published on 10/29/2026 at 07:20, 8 hours 19 minutes ago Q3 2026: Air Liquide accelerates, driven by sales growth and the launch of its strategic plan
Published on 10/29/2026 at 07:20, 8 hours 19 minutes ago T3 2026 : Air Liquide accélère, porté par des ventes en croissance et le lancement de son plan stratégique
